Skip to main content
logo
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.31
-1.86 (-8.79%)
At close: Oct 6, 2026, 4:00 PM EDT
19.13
-0.18 (-0.93%)
Pre-market: Oct 7, 2026, 8:15 AM EDT

Immunome Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,1932,37066345727157
Market Cap Growth
103.52%257.53%44.98%1605.70%-82.91%53.68%
Enterprise Value
1,6782,101425367-0101
Last Close Price
19.3121.4810.6210.702.2112.96

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-341.4473.3232.62--
PB Ratio
4.173.743.663.811.613.26
P/TBV Ratio
4.183.743.663.811.613.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-302.7447.0626.18--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.030.010.02-
Net Debt / Equity Ratio
-0.98-1.02-1.17-1.14-1.20-1.02
Net Debt / EBITDA Ratio
2.003.071.404.830.552.01
Net Debt / FCF Ratio
2.353.241.8016.250.692.69
Asset Turnover
-0.020.050.16--
Quick Ratio
14.6414.534.006.332.895.50
Current Ratio
15.0814.694.086.633.095.82
Return on Equity (ROE)
-64.03%-52.09%-194.63%-156.45%-113.81%-55.20%
Return on Assets (ROA)
-37.79%-28.98%-49.34%-20.81%-56.27%-30.75%
Return on Capital Employed (ROCE)
-49.20%-33.50%-82.50%-22.70%-220.80%-52.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.60%-8.96%-44.20%-23.36%-137.65%-15.76%
FCF Yield
-9.99%-8.46%-17.80%-1.84%-107.96%-11.67%
Buyback Yield / Dilution
-41.38%-48.96%-195.51%-63.64%-5.10%-240.41%
SEC Filings: 10-K · 10-Q